Warning letter
AngioDynamics, Inc. [ARCHIVED]: warning letter of May 27, 2011
FDA warning letter 174433 · New York District Office
Key facts
| Reference number | 174433 |
|---|---|
| Company | AngioDynamics, Inc. [ARCHIVED] |
| Subject | Medical Device Reporting Regulation/Misbranded |
| Issue date | May 27, 2011 |
| Posted date | May 27, 2011 |
| Issuing office | New York District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.52, 806, 803.50(a)(1), 806.10(a)(1), 820, 803.50(b) |
| Inspection city | Queensbury |
| Inspection ZIP | 12804 |
| Inspection start date | Jan 4, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: